Peter Molhoek

Effect of Ranolazine, an Antianginal Agent With Novel Electrophysiological Properties, on the Incidence of Arrhythmias in Patients With Non–ST-Segment–Elevation Acute Coronary Syndrome

Benjamin M. Scirica, David A. Morrow, Hanoch Hod et al. · Circulation · 2007 · 441 citations · Full text

Medicine, Cardiology, Pharmacology +17

Randomized Comparison of Enoxaparin, a Low-Molecular-Weight Heparin, With Unfractionated Heparin Adjunctive to Recombinant Tissue Plasminogen Activator Thrombolysis and Aspirin

Allan M. Ross, Peter Molhoek, Conor F. Lundergan et al. · Circulation · 2001 · 173 citations · Full text

Medicine, Cardiology, Pharmacology +16

Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis

Roberto R. Giraldez, José Carlos Nicolau, Ramón Corbalán et al. · European Heart Journal · 2007 · 75 citations

Medicine, Cardiology, Pharmacotherapy +15

Effects of thrombolytic therapy in acute inferior myocardial infarction with or without right ventricular involvement

Uwe Zeymer, Karl-Ludwig Neuhaus, Karl Wegscheider et al. · Journal of the American College of Cardiology · 1998 · 74 citations

Medicine, Cardiology, Internal Medicine +14

Collaborative angiographic patency trial of recombinant staphylokinase (CAPTORS II)

Paul W. Armstrong, Jeff Burton, Steve Pakola et al. · American Heart Journal · 2003 · 49 citations

Medicine, Cardiology, Interventional Cardiology +10